ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0712

Effects of Bacterial Secretome on Nasal Epithelial Cell Gene Expression in ANCA-Associated Vasculitis

A. Nikolai von Krusenstiern1, Eleni Bouziani2, Sokratis Apostolidis2, Li Hui Tan2, Swetha Rajagopal3, Nicholas Bolden2, Paul J. Planet3, Dylan Curry3, Elliot Friedman3, Noam A. Cohen4 and Rennie Rhee2, 1Hospital of the University of Pennsylvania, Philadelphia, PA, 2University of Pennsylvania, Philadelphia, PA, 3Children’s Hospital of Philadelphia, Philadelphia, PA, 4University of Pennsylvania, Philadelphia

Meeting: ACR Convergence 2025

Keywords: ANCA associated vasculitis, microbiome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0711–0730) Vasculitis – ANCA-Associated Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: The nasal microbiome has been implicated as a contributor to relapse in ANCA-associated vasculitis (AAV). Previous research on nasal bacteria, particularly Staphylococcus aureus, has focused on interactions with circulating immune cells and mediators in the blood. However, alterations in the antibacterial responses of nasal epithelial cells, an understudied cell population in AAV, and their contribution to systemic relapse in AAV are still poorly understood. The aim of this study is to compare the effects of bacterial secreted proteins (secretome) on primary human nasal epithelial cells (HNECs) derived from patients with AAV versus healthy controls.

Methods: Primary HNECs from 3 patients with AAV and 3 healthy controls were cultured at air-liquid interface, which mimics air-facing nasal epithelium. Patients with AAV met 2022 ACR-EULAR classification criteria for granulomatosis with polyangiitis. Bacterial cell-free supernatant was obtained from a co-culture of two bacterial strains (S. aureus and Corynebacterium tuberculostearicum) isolated from a nasal swab of a patient with relapsing AAV; these two strains were selected based on a previous study of the nasal microbiome in AAV. HNECs were stimulated with the bacterial supernatants and then harvested for RNA sequencing to evaluate for differential changes in gene expression using FDR-corrected P < 0.001.

Results: RNA-seq of HNECs stimulated with bacterial supernatant revealed differences in transcriptional response between AAV and controls (Figure 1). Increased expression of genes related to angiogenesis, extracellular matrix modification, and cell cycle pathways were observed in AAV vs controls. Intracellular pathways upregulated in AAV included Wnt signaling, MAPK, and PI3K-Akt signaling, indicating a heightened activation state. Genes related to neutrophil biology were upregulated in AAV vs control including PADI2, LTF, and CD177. Down-regulated transcripts included pathways related to immune signaling, complement and coagulation cascade, extracellular matrix receptor interaction and adhesion, and mucin and barrier function, indicating an attenuated barrier repair and innate immune program upon bacterial challenge in AAV.

Conclusion: Nasal epithelial cell cultures derived from patients with AAV display an altered transcriptional response to bacterial secretome. Specifically, impaired host defenses, including barrier function and innate immune responses, were observed. These findings suggest antibacterial responses are significantly altered in the nasal epithelium of patients with AAV. Mechanistic studies are needed to elucidate the role of these changes in relapsing AAV, which eventually may identify novel targets for treatment or prevention of disease flares.

Supporting image 1Figure 1. Transcriptional changes after bacterial challenge of primary human nasal epithelial cell cultures of ANCA-associated vasculitis vs healthy controls. Volcano plot showing log2FC on the x-axis and -log10(adjusted p-value) on y-axis. Genes meeting significance (FDR P < 0.001 and |log2FC| > 2) are highlighted in red and labeled.


Disclosures: A. von Krusenstiern: None; E. Bouziani: None; S. Apostolidis: None; L. Tan: None; S. Rajagopal: None; N. Bolden: None; P. Planet: None; D. Curry: None; E. Friedman: None; N. Cohen: None; R. Rhee: None.

To cite this abstract in AMA style:

von Krusenstiern A, Bouziani E, Apostolidis S, Tan L, Rajagopal S, Bolden N, Planet P, Curry D, Friedman E, Cohen N, Rhee R. Effects of Bacterial Secretome on Nasal Epithelial Cell Gene Expression in ANCA-Associated Vasculitis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/effects-of-bacterial-secretome-on-nasal-epithelial-cell-gene-expression-in-anca-associated-vasculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effects-of-bacterial-secretome-on-nasal-epithelial-cell-gene-expression-in-anca-associated-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology